Spyre Therapeutics, Inc. (NASDAQ:SYRE) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Felix Baker Other companies: BeOne Medicines Ltd. Class A (Director · Since at least Nov 6, 2026); Denali Therapeutics Inc. (Director · Since at least Jun 3, 2025); Replimune Group, Inc. (Director · Since at least Mar 5, 2025); Bicycle Therapeutics PLC (Director · Since at least Apr 18, 2024); Kymera Therapeutics, Inc. (Chairman · Since at least Mar 28, 2024); vTv Therapeutics Inc. (Director · Since at least Feb 27, 2024); Madrigal Pharmaceuticals, Inc. (Director · Since at least Jun 15, 2023); TScan Therapeutics, Inc. (Director · Since at least Jul 15, 2021); DBV Technologies SA (Director · Since at least Jan 1, 2021); Prelude Therapeutics Incorporated (Director · Since at least Mar 27, 2020); IGM Biosciences Inc (Director · Since at least Sep 17, 2019); Kodiak Sciences Inc (Director · Since at least Oct 3, 2018); Kiniksa Pharmaceuticals International, plc (Lead Director · Since at least Feb 9, 2018); ACADIA Pharmaceuticals Inc. (Director · Since at least Jan 18, 2013); Incyte Corporation (Director · Since at least Jan 4, 2008); Immunocore Holdings plc (Director · May 28, 2024 – May 15, 2025 · Past); Talis Biomedical Corp (Director · Nov 2, 2020 – Jun 9, 2023 · Past); Zymeworks Inc. (Director · Mar 16, 2020 – May 8, 2020 · Past); Neurogene Inc. (Director · May 8, 2017 – Dec 18, 2023 · Past); Alexion Pharmaceuticals Inc (Director · Jun 22, 2015 – May 14, 2020 · Past); Aceragen Inc. (Director · Mar 10, 2014 – Apr 1, 2019 · Past); Ardea Biosciences Inc (Director · Feb 8, 2010 – Jun 19, 2012 · Past); Synageva BioPharma Corp (Director · Aug 14, 2007 – Jun 22, 2015 · Past); Neurogen Corp (Director · Jun 7, 2007 – Jul 25, 2008 · Past); Seagen Inc (Director · May 25, 2007 – Dec 14, 2023 · Past); Genomic Health Inc (Director · May 21, 2007 – Oct 1, 2019 · Past) | Director · Feb 23, 2021 – Jun 8, 2021 · Past |
| Julian Baker Other companies: Denali Therapeutics Inc. (Director · Since at least Jun 3, 2025); Replimune Group, Inc. (Director · Since at least Mar 5, 2025); Bicycle Therapeutics PLC (Director · Since at least Apr 18, 2024); Kymera Therapeutics, Inc. (Director · Since at least Mar 28, 2024); vTv Therapeutics Inc. (Director · Since at least Feb 27, 2024); Madrigal Pharmaceuticals, Inc. (Director · Since at least Jun 15, 2023); TScan Therapeutics, Inc. (Director · Since at least Jul 15, 2021); DBV Technologies SA (Director · Since at least Jan 1, 2021); Prelude Therapeutics Incorporated (Director · Since at least Mar 27, 2020); IGM Biosciences Inc (Director · Since at least Sep 17, 2019); Kodiak Sciences Inc (Director · Since at least Oct 3, 2018); Kiniksa Pharmaceuticals International, plc (Director · Since at least Feb 9, 2018); ACADIA Pharmaceuticals Inc. (Director · Since at least Jan 18, 2013); Incyte Corporation (Managing Partner, Baker Brothers Investments | Chairman, Incyte · Since at least Apr 25, 2006); Immunocore Holdings plc (Director · May 28, 2024 – May 15, 2025 · Past); Talis Biomedical Corp (Director · Nov 2, 2020 – Jun 9, 2023 · Past); Zymeworks Inc. (Director · Mar 16, 2020 – May 8, 2020 · Past); Neurogene Inc. (Director · May 8, 2017 – Dec 18, 2023 · Past); Alexion Pharmaceuticals Inc (Director · Jun 22, 2015 – May 14, 2020 · Past); Aceragen Inc. (Director · Mar 10, 2014 – Apr 1, 2019 · Past); Ardea Biosciences Inc (Director · Apr 6, 2010 – Jun 19, 2012 · Past); Seagen Inc (Director · Jun 9, 2006 – Dec 14, 2023 · Past); Innoviva, Inc. (Director · Apr 26, 2006 – Apr 26, 2006 · Past); Genomic Health Inc (Director · Apr 25, 2006 – Oct 1, 2019 · Past); Synageva BioPharma Corp (Director · Apr 25, 2006 – Jun 22, 2015 · Past); Neurogen Corp (Director · Mar 15, 2006 – Dec 15, 2009 · Past) | Director · Feb 23, 2021 – Jun 8, 2021 · Past |
| Peter Harwin Other companies: Damora Therapeutics, Inc. (Chairman of the Board · Since at least Nov 10, 2025); Crescent Biopharma, Inc. (Chair of Board · Since at least Jun 13, 2025); Jade Biosciences, Inc. (Director · Since at least Apr 28, 2025); Zenas BioPharma, Inc. (Director · Since at least Sep 12, 2024); Oruka Therapeutics, Inc. (Director · Since at least Aug 29, 2024); Apogee Therapeutics, Inc. (Director · Since at least Jul 13, 2023); Cogent Biosciences, Inc. (Founding Partner, Fairmount Funds Management LLC · Since at least Jul 6, 2020); Dianthus Therapeutics, Inc. (Director · Sep 11, 2023 – Jan 22, 2024 · Past); Viridian Therapeutics, Inc. (Director · Oct 27, 2020 – Jun 26, 2024 · Past) | Director · Since at least Jun 22, 2023 |
| Alison Frances Lawton Other companies: ProQR Therapeutics N.V. (Director · Since at least Mar 18, 2026); Dianthus Therapeutics, Inc. (Director · Since at least Dec 22, 2020); X4 Pharmaceuticals, Inc. (Director · Oct 5, 2020 – Jun 10, 2024 · Past); Kaleido Biosciences, Inc. (See Remarks, Director · Feb 27, 2019 – Apr 15, 2020 · Past); CoLucid Pharmaceuticals Inc (Director · Mar 11, 2016 – Mar 1, 2017 · Past); Tempest Therapeutics, Inc. (Chief Operating Officer · Jan 21, 2013 – Jun 7, 2013 · Past); Verastem, Inc. (Director · Nov 26, 2012 – Jun 21, 2019 · Past); Cubist Pharmaceuticals Inc (Director · Feb 15, 2012 – Jan 21, 2015 · Past) | Director · Dec 15, 2020 – Jun 22, 2023 · Past |
| Tomas Kiselak Other companies: Cyclerion Therapeutics, Inc. (Chairman · Since at least Apr 1, 2026); Crescent Biopharma, Inc. (Director · Since at least Jun 13, 2025); Jade Biosciences, Inc. (Director · Since at least Apr 28, 2025); Zenas BioPharma, Inc. (Director · Since at least Sep 12, 2024); Oruka Therapeutics, Inc. (Director · Since at least Aug 29, 2024); Apogee Therapeutics, Inc. (Director · Since at least Jul 13, 2023); Viridian Therapeutics, Inc. (Director · Since at least Oct 27, 2020); Dianthus Therapeutics, Inc. (Director · Sep 11, 2023 – Sep 27, 2024 · Past) | Director · Since at least Jun 22, 2023 |
| Mark McKenna Other companies: Helix Acquisition Corp. III (Director · Since at least Jan 22, 2026); NewAmsterdam Pharma Company N.V. (Director · Since at least Jul 16, 2024); Apogee Therapeutics, Inc. (Director · Since at least Aug 17, 2023); Freenome, Inc. (Director · Jun 11, 2024 – Jun 11, 2024 · Past); BridgeBio Oncology Therapeutics, Inc. (Director · Feb 8, 2024 – Feb 8, 2024 · Past); Prometheus Biosciences Inc (Chairman, President and CEO, Director · Mar 11, 2021 – Jun 16, 2023 · Past); Bausch Health Companies Inc. (President, Salix · Aug 2, 2018 – Aug 19, 2019 · Past) | Board Member · Since at least Feb 1, 2024 |
| Suzanne L. Bruhn Other companies: Definium Therapeutics, Inc. (Director · Since at least Aug 11, 2022); Vigil Neuroscience Inc (Director · Since at least Jul 27, 2022); Pliant Therapeutics, Inc. (Director · Since at least Jun 2, 2020); Travere Therapeutics, Inc. (Director · Since at least Apr 8, 2020); Avalo Therapeutics, Inc. (Director · Apr 24, 2020 – Nov 10, 2021 · Past); Novelion Therapeutics Inc (Director · Oct 1, 2017 – Aug 9, 2018 · Past); Raptor Pharmaceutical Corp (Director · Sep 25, 2012 – Oct 24, 2016 · Past) | Director · Feb 15, 2017 – Jun 8, 2020 · Past |
| V Bryan Lawlis Other companies: Sutro Biopharma, Inc. (Director · Sep 26, 2018 – Sep 26, 2018 · Past); Coherus Oncology, Inc. (Director · Nov 6, 2014 – Jan 11, 2021 · Past); Humanigen Inc (Director · Aug 7, 2013 – Jun 18, 2014 · Past); BioMarin Pharmaceutical Inc. (Director · May 8, 2012 – May 23, 2023 · Past); Geron Corporation (Director · Mar 13, 2012 – May 21, 2025 · Past) | Director · Jul 13, 2018 – Jun 7, 2022 · Past |
| Cameron Turtle Other companies: Damora Therapeutics, Inc. (Board Director · Since at least Mar 23, 2026); Oruka Therapeutics, Inc. (Director · Since at least Aug 29, 2024); BridgeBio Pharma, Inc. (See Remarks · Jun 27, 2019 – Dec 28, 2020 · Past); Eidos Therapeutics Inc (Chief Business Officer · Nov 5, 2018 – Jan 26, 2021 · Past) | Chief Executive Officer · Since at least Jun 22, 2023 |
| Ivana Magovčević-Liebisch Other companies: Quanterix Corporation (Director · Since at least Oct 2, 2024); Acrivon Therapeutics, Inc. (Director · Since at least Feb 8, 2024); Vigil Neuroscience Inc (President and CEO, Director · Since at least Jan 6, 2022); Absci Corporation (Director · Jul 21, 2021 – Jun 8, 2022 · Past) | Director · Jun 8, 2021 – Jun 22, 2023 · Past |
| Laurie Stelzer Other companies: MBX Biosciences, Inc. (Director · Since at least Jan 20, 2026); Sionna Therapeutics, Inc. (Director · Since at least Feb 6, 2025); PMV Pharmaceuticals, Inc. (Chair, Board of Directors · Since at least Jun 2, 2022); Surface Oncology Inc (Director · Jun 8, 2022 – Jun 8, 2022 · Past) | Chair of the Audit Committee · Since at least Nov 22, 2023 |
| Sandesh Mahatme Other companies: Vor Biopharma Inc. (CFO · Since at least Jul 9, 2025); CRISPR Therapeutics AG (Director · Since at least May 30, 2024); Flexion Therapeutics Inc (Director · Jul 22, 2014 – Jun 10, 2020 · Past); Sarepta Therapeutics, Inc. (EVP, CFO & CBO · Nov 5, 2012 – May 11, 2020 · Past) | Director · Apr 6, 2016 – Jun 7, 2022 · Past |
| Armen Shanafelt Other companies: Surface Oncology Inc (Director · Apr 18, 2018 – Jun 8, 2022 · Past); Rein Therapeutics, Inc. (Director · Jun 28, 2017 – Jun 21, 2018 · Past); Protagonist Therapeutics, Inc. (Director · Aug 10, 2016 – May 29, 2018 · Past) | Director · Apr 6, 2016 – Jun 7, 2022 · Past |
| Jeffrey Albers Other companies: Kymera Therapeutics, Inc. (Director · Since at least Aug 20, 2020); Blueprint Medicines Corp (Director · Since at least Apr 30, 2015); Dianthus Therapeutics, Inc. (Director · Jun 20, 2018 – Jun 28, 2022 · Past) | Director · Since at least Nov 22, 2023 |
| Marcio Souza Other companies: Praxis Precision Medicines, Inc. (President & Chief Executive Officer · Since at least Oct 15, 2020); ClearPoint Neuro Inc. (Director · May 17, 2019 – May 17, 2019 · Past); PTC Therapeutics, Inc. (Chief Operating Officer · May 31, 2017 – Feb 10, 2020 · Past) | Director · Jun 18, 2021 – Aug 25, 2022 · Past |
| Michael Henderson Other companies: Apogee Therapeutics, Inc. (Chief Executive Officer · Since at least Jul 13, 2023); ARYA Sciences Acquisition IV Corp (Director · Feb 25, 2021 – Jul 31, 2024 · Past); BridgeBio Pharma, Inc. (Chief Business Officer · Jun 27, 2019 – Dec 15, 2020 · Past) | Board Member · Since at least Jun 22, 2023 |
| Russell J. Cox Other companies: Gossamer Bio, Inc. (Director · Since at least Feb 7, 2019); Immunic, Inc. (Chief Executive Officer, Director · Jan 3, 2018 – Jan 11, 2019 · Past); Jazz Pharmaceuticals plc (EVP & COO · Feb 8, 2011 – Dec 11, 2017 · Past) | Director · Apr 6, 2016 – Jun 22, 2023 · Past |
| Sandra Milligan Other companies: Gossamer Bio, Inc. (Director · Since at least Jun 10, 2021); Aspira Women's Health Inc. (Interim CEO & President · Apr 1, 2024 – Dec 31, 2024 · Past); Organon & Co. (Head of Research & Development · Jun 2, 2021 – May 4, 2023 · Past) | Chair of the Nominating and Corporate Governance Committee · Since at least May 14, 2024 |
| Hunter Smith Other companies: Rhythm Pharmaceuticals, Inc. (Chief Financial Officer and Treasurer · Since at least Oct 4, 2017); Genesee & Wyoming Inc (Director · Jun 30, 2015 – Dec 30, 2019 · Past) | Director · Nov 12, 2021 – Jun 22, 2023 · Past |
| James Kastenmayer Other companies: ArriVent BioPharma, Inc. (General Counsel · Since at least Jan 25, 2024); Viela Bio Inc (General Counsel · Jan 6, 2020 – Mar 15, 2021 · Past) | General Counsel · Aug 23, 2022 – Feb 23, 2023 · Past |
| Madduri Ravin Rao Other companies: Autolus Therapeutics plc (Director · Since at least Mar 18, 2026); DBV Technologies SA (Director · May 19, 2021 – Jun 10, 2021 · Past) | Chief Medical Officer · Nov 1, 2019 – Feb 14, 2020 · Past |
| Aaron Schuchart Other companies: Lumos Pharma Inc (Chief Business Officer · May 19, 2021 – Dec 12, 2024 · Past) | Chief Business Officer · May 22, 2017 – Feb 28, 2019 · Past |
| Charles N York II Other companies: Day One Biopharmaceuticals Inc (COO and CFO · Since at least May 26, 2021) | Chief Financial Officer and VP · Apr 6, 2016 – Feb 14, 2020 · Past |
| Jeff Marc Goldberg Other companies: Akcea Therapeutics Inc (Chief Operating Officer · Jan 2, 2018 – Sep 26, 2019 · Past) | President and CEO, Director · Nov 29, 2022 – Nov 29, 2022 · Past |
| Sandra Rojas-Caro Other companies: NeuBase Therapeutics Inc (Chief Medical Officer · May 24, 2021 – Jan 24, 2022 · Past) | Chief Medical Officer · May 17, 2016 – May 17, 2016 · Past |
| Scott L Burrows Other companies: Arcutis Biotherapeutics, Inc. (Chief Financial Officer · Apr 1, 2021 – Mar 6, 2023 · Past) | Chief Financial Officer · Since at least Sep 1, 2023 |
| David George Lowe | CEO and President, Director · Apr 6, 2016 – Mar 20, 2017 · Past |
| Eric McIntyre | SVP of Finance and Investor Relations · Since at least Nov 3, 2026 |
| George Georgiou | Director · Apr 6, 2016 – Aug 13, 2018 · Past |
| Heidy King-Jones | See Remarks · Since at least Feb 1, 2024 |
| Jeff Albers | Chair of the Compensation Committee · Since at least Aug 10, 2026 |
| Jonathan Alspaugh | President and CFO · Jul 6, 2021 – Jun 22, 2023 · Past |
| Joseph E Tyler | VP, Manufacturing · Apr 6, 2016 – Aug 22, 2017 · Past |
| Leslie Sloan | Chief Operating Officer · Mar 6, 2019 – Aug 23, 2022 · Past |
| Linda L Neuman | Chief Medical Officer · Nov 14, 2022 – Feb 23, 2023 · Past |
| Sara Brownstein | Director · Feb 23, 2021 – Feb 23, 2021 · Past |
| Scott W Rowlinson | VP, Research · Apr 6, 2016 – Aug 22, 2017 · Past |
| Sheldon Sloan | Chief Medical Officer · Since at least Oct 1, 2024 |